<div dir="ltr"><div dir="ltr"><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span lang="ES" style="font-size:11pt;font-family:Arial,sans-serif;color:black">(</span><span style="font-size:11pt;font-family:Arial,sans-serif;color:black">Apologies for cross-posting)</span><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" align="center" style="margin:0cm;text-align:center;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black"><span class="gmail-il">Final CFP</span> <span class="gmail-il">MultiCardioNER</span> (CLEF/BioASQ 2024): Clinical Named Entity Recognition adaptation shared task (multilingual & cardiology)</span></b></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" align="center" style="margin:0cm;text-align:center;font-size:12pt;font-family:Calibri,sans-serif"><u><span style="font-size:10pt;color:rgb(17,85,204)"><a href="https://temu.bsc.es/multicardioner/" target="_blank" style="color:blue">https://temu.bsc.es/<span class="gmail-il">multicardioner</span>/</a></span></u><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" align="center" style="margin:0cm;text-align:center;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:11pt;font-family:Arial,sans-serif;color:black"> </span><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" style="margin:0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">The </span><span lang="EN-US" style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span></span><span style="font-size:10pt;color:black"> track focuses on the</span><span style="font-size:10pt;color:black"> <span lang="EN-US">adaptation of clinical <span class="gmail-il">NER</span> systems to specific high impact clinical application domains (</span></span><span style="font-size:10pt;color:black">cardiovascular diseases</span><span lang="EN-US" style="font-size:10pt;color:black">,</span><span lang="EN-US" style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">the leading cause of death globally</span><span lang="EN-US" style="font-size:10pt;color:black">) as well as to multiple languages (<b>English, Spanish and Italian</b>), focusing on two clinical entity types: diseases and medications.</span><span style="font-size:10pt;color:black"></span></p><p class="MsoNormal" style="margin:0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Key information:</span></b><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><b><span style="font-size:10pt;color:black">Web</span></b><span style="font-size:10pt;color:black">: <a href="https://temu.bsc.es/multicardioner" target="_blank">https://temu.bsc.es/<span class="gmail-il">multicardioner</span></a></span><span style="font-size:10pt;font-family:Arial,sans-serif;color:black"></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><b><span style="font-size:10pt;color:black">Data</span></b><span style="font-size:10pt;color:black">:</span> <span style="font-size:10pt;font-family:Arial,sans-serif;color:black"></span><span style="font-family:Arial,Helvetica,sans-serif;font-size:small"><a href="https://zenodo.org/records/11103522">https://zenodo.org/records/11103522</a></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><b><span lang="EN-US" style="font-size:10pt;color:black">BioASQ</span></b><b><span style="font-size:10pt;color:black"> web</span></b><span style="font-size:10pt;color:black">: <a href="http://bioasq.org/" target="_blank">http://bioasq.org/</a></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><b><span style="font-size:10pt;color:black">Registration</span></b><b><span lang="EN-US" style="font-size:10pt;color:black">:</span></b><b><span lang="EN-US" style="font-size:10pt;color:black"> </span></b><span style="font-size:10pt;color:black"><a href="https://temu.bsc.es/multicardioner/registration/" target="_blank">https://temu.bsc.es/<span class="gmail-il">multicardioner</span>/registration/</a></span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:rgb(17,85,204)"><br></span><b><span style="font-size:10pt;color:black">Motivation<br></span></b><span style="font-size:10pt;color:black">The extraction of clinical variables from medical content is key to enable efficient healthcare data analytics. Due to the highly specialized medical language, with considerable variation depending on the medical </span><span lang="EN-US" style="font-size:10pt;color:black">discipline</span><span style="font-size:10pt;color:black">, more specialized automatic semantic annotation resources are needed, not only for English but also other languages.</span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">This is particularly true for clinical content related to cardiovascular diseases (CVDs), which represent the leading cause of death globally, responsible for approximately 17.9 million deaths/year.</span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span lang="EN-US" style="font-size:10pt;color:black">The</span><span lang="EN-US" style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> </span><span lang="EN-US" style="font-size:10pt;color:black">task </span><span style="font-size:10pt;color:black">will focus on the automatic recognition of two key clinical variables or concept types, namely diseases and medications</span><span style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">in cardiology clinical case documents with the following two aims:</span></p><p style="margin:10pt 0cm 0cm 36pt;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Adaptation of general clinical concept recognition systems to cardiology case reports to assess and determine how well such systems can be adapted to high impact clinical application domains / specialties (cardiology disease <span class="gmail-il">NER</span> - CardioDis subtrack: Spanish).</span></p><p style="margin:10pt 0cm 0cm 36pt;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Promote the comparative assessment and development of clinical entity recognition systems for multiple languages (i.e., medication mention detection) as well as adaptation to specific medical specialties (MultiDrug subtrack: English, Spanish and Italian)</span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">To enable the adaptation of general medical <span class="gmail-il">NER</span> systems for diseases and medications the <span class="gmail-il">MultiCardioNER</span> task will rely on a training collection of 1000 general clinical case reports in Spanish annotated with diseases (Spanish) and medications (English, Spanish and Italian).</span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">Moreover, </span><span lang="EN-US" style="font-size:10pt;color:black">t</span><span style="font-size:10pt;color:black">o be able to adapt such general medical <span class="gmail-il">NER</span> approaches to cardiology case reports a development set of 250 cardiology cases will be released.</span><span style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">The test set will consist of an additional test collection of 250 cardiology case reports</span><span lang="EN-US" style="font-size:10pt;color:black">.</span></p><p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">The evaluation of systems for this task will use flat evaluation, mainly micro-averaged Precision, Recall and F-measure (MiF).</span></p><p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:12pt;font-family:Calibri,sans-serif"><span lang="ES" style="font-family:Arial,sans-serif">S</span><span style="font-size:10pt;color:black">ub-tracks:</span><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Subtask 1 (CardioDis): </span></b><span style="font-size:10pt;color:black">Spanish adaptation of disease recognition systems to the cardiology domain<b></b></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black"> </span></b></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Subtask 2 (MultiDrug): </span></b><span style="font-size:10pt;color:black">Multilingual (Spanish, English and Italian) adaptation of medication recognition systems to the cardiology domain<br><b><br></b></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><b><br></b></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><b>Tentative schedule</b></span><span style="font-family:Arial,sans-serif"></span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> Train+Dev Set Release           April 9th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> Annotation Guidelines Release            April 17th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> Gazetteer Release  April 17th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> Test Set Texts Release            May 2nd, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Participant Test Predictions Deadline  </span><span style="color:black;font-size:10pt">May 15th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Participant Evaluation Result Release               May 19th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Submission of Participant Papers Deadline     May 31st, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Notification of Acceptance of Participant Papers           June 24th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">       </span></span><span style="font-size:10pt;color:black">Submission of Camera-ready Participant Papers Deadline           July 8th, 2024</span></p><p style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">      </span></span><span style="font-size:10pt;color:black">BioASQ @ CLEF2024             September 9th-12th, 2024<br><br><br></span><span style="font-family:Arial,sans-serif"></span></p><p style="margin:0cm;background-image:initial;background-position:initial;background-size:initial;background-repeat:initial;background-origin:initial;background-clip:initial;font-size:12pt;font-family:"Times New Roman",serif"><b><span style="font-size:10pt;font-family:Arial,sans-serif">Publications & conference</span></b><span style="font-size:10pt;font-family:Arial,sans-serif"></span></p><p style="margin:0cm;text-align:justify;background-image:initial;background-position:initial;background-size:initial;background-repeat:initial;background-origin:initial;background-clip:initial;font-size:12pt;font-family:"Times New Roman",serif"><span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal"><span style="font-size:10pt;font-family:Arial,sans-serif">Following previous BioASQ/CLEF efforts, participating teams will be invited to contribute a short systems description paper for the CLEF 202</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">4</span><span style="font-size:10pt;font-family:Arial,sans-serif"> proceedings, and to give a short presentation of their approach at the BioASQ workshop at the CLEF 202</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">4</span><span style="font-size:10pt;font-family:Arial,sans-serif"> conference (September 09-12, 2024, in Grenoble</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">, </span><span style="font-size:10pt;font-family:Arial,sans-serif">France)</span></span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><br></span><span style="font-family:Arial,sans-serif"></span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><br></span><b><span style="font-size:10pt;color:black">The </span></b><b><span lang="EN-GB" style="font-size:10pt;color:black"><span class="gmail-il">MultiCardioNER</span> Organizers & collaborators:</span></b><b><span lang="ES" style="font-size:10pt;color:black"></span></b></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><b><span lang="ES" style="font-size:10pt;color:black"> </span></b></p><ul type="disc" style="margin-top:0cm;margin-bottom:0cm"><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Salvador Lima-López, Barcelona Supercomputing Center (BSC), Spain</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Eulàlia Farré-Maduell, Barcelona Supercomputing Center (BSC), Spain</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jan Rodríguez-Miret, Barcelona Supercomputing Center (BSC), Spain</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Martin Krallinger, Barcelona Supercomputing Center (BSC), Spain</span></li></ul><ul type="disc" style="margin-top:0cm;margin-bottom:0cm"><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anastasios Nentidis, National Center for Scientific Research Demokritos, Greece</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anastasia Krithara, National Center for Scientific Research Demokritos, Greece</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Georgios Katsimpras, National Center for Scientific Research Demokritos, Greece</span></li></ul><ul type="disc" style="margin-top:0cm;margin-bottom:0cm"><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Livia Lilli, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jacopo Lenkowicz, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jonathan Kossoff, University College London Hospitals NHS Foundation Trust, UK</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Giovanna Ceroni, University College London, UK</span></li><li class="MsoNormal" style="margin:0cm;color:black;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anoop Shah, University College London Hospitals NHS Foundation Trust, UK</span></li></ul><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"><br><br></span></p><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p><div>=======================================<br>Martin Krallinger, Dr.<br><span style="font-family:arial,helvetica,sans-serif">Head of NLP for Biomedical Information Analysis Unit<br></span><span style="font-family:arial,helvetica,sans-serif">Barcelona Supercomputing Center (BSC-CNS)</span></div><div><font face="arial, helvetica, sans-serif"><a href="https://www.linkedin.com/in/martin-krallinger-85495920/" target="_blank">https://www.linkedin.com/in/martin-krallinger-85495920/</a><br></font> =======================================</div></div></div>